Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 6.180 | 6.180 | 0.000 |
Shares | 94.020 | 94.020 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 27.202 | 21.169 |
Price to Book | 3.294 | 2.532 |
Price to Sales | 4.516 | 2.940 |
Price to Cash Flow | 10.511 | 12.483 |
Dividend Yield | 0.405 | 2.224 |
5 Years Earnings Growth | 6.997 | 11.690 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 98.540 | 97.348 |
Consumer Cyclical | 1.440 | 0.953 |
Technology | 0.010 | 0.432 |
Number of long holdings: 100
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Beigene | CNE100005XT6 | 9.96 | 164.79 | +1.72% | |
Jiangsu Hengrui | CNE0000014W7 | 8.35 | 46.07 | -1.12% | |
Shouyao Holdings Beijing | CNE1000062V6 | 7.56 | 33.72 | -1.72% | |
RemeGen | CNE100005B03 | 6.47 | 34.64 | -0.20% | |
Dizal Jiangsu Pharmaceutical | CNE1000055W8 | 5.15 | 45.31 | -1.07% | |
Sichuan Biokin Pharmaceutical | CNE100006FN4 | 5.06 | 203.40 | +1.80% | |
InnoCare Pharma | CNE100005P56 | 4.97 | 13.39 | -1.76% | |
Gan Lee Pharmaceuticals | CNE100003ZH1 | 4.81 | 46.52 | +0.71% | |
Kelun Pharm A | CNE100000PW7 | 4.38 | 31.55 | -0.47% | |
Mabwell Shanghai Bioscience | CNE100005RD2 | 3.96 | 21.19 | -6.65% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Penghua Jiangxin Sele Alloc C | 8.45B | -2.57 | -10.47 | - | ||
Penghua HongKang mix A | 6.18B | 2.05 | 2.88 | - | ||
Penghua HongKang mix C | 6.18B | 1.96 | 2.78 | - | ||
Penghua China Secs Wine Index Fd | 3.39B | -7.64 | -11.33 | - | ||
Penghua CSI Guofang Idx Classified | 3.33B | 2.90 | -16.32 | -1.37 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review